C

Creighton University | Clinical Research Office

Research site

(Unclaimed)

Location

7710 Mercy Road, Suite 228, Omaha, Nebraska, United States of America

Site insights

Top conditions

Top treatments

BI 1015550

Nintedanib

Calcium

Risperidone

Olanzapine

Teriparatide

Chlorthalidone

Rasagiline

Carbidopa

Bexotegrast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 110 total trials

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling

Cough

Refractory Chronic Cough

Drug: Placebo

Drug: BLU-5937

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Enrolling

Progressive Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Drug: BI 1015550

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called...

Enrolling

Schizophrenia

Device: Digital therapeutic (CT-155)